Company / Net Income
PTC Therapeutics, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$682.6M
FY2025
5-year range
-$626.6M / $682.6M
FY2021-FY2025
Trend
+287.9%
vs FY2024
Sector context
#20 of 216
Health Care
What the data says
Net Income changed +288% YoY in FY2025, a notable deviation from the 9-year average annual change of +6%.
Based on SEC 10-K filings.
$683M in FY2025. Top quartile in the Health Care sector.
Improved from -$627M to $683M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 216This company $682.6M Sector average $454.1M
▼
+50.3% above sector average
Key checks
Key Insights
- In FY2025, net income increased 287.9% year-over-year.
- Ranks #20 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $682.6M | +287.9% |
| FY2024 | -$363.3M | +42.0% |
| FY2023 | -$626.6M | -43.0% |
| FY2022 | -$438.2M | -74.2% |
| FY2021 | -$251.6M | -96.4% |
| FY2020 | -$128.1M | +49.1% |
| FY2019 | -$251.6M | -96.4% |
| FY2018 | -$128.1M | -62.1% |
| FY2017 | -$79.0M | +44.4% |
| FY2016 | -$142.1M | +16.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026